Skip to content

Clinical trials

Terminated Observational Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Observational Status: Terminated Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20083
20102
20131
20141
20151
20172
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb1
Celgene1
Centre Hospitalier Universitaire de Saint Etienne1
Centre Hospitalier Universitaire, Amiens1
City of Hope Medical Center1
Columbia University1
CureOne1
Fred Hutchinson Cancer Center1
M.D. Anderson Cancer Center1
OHSU Knight Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes15
Leukemia, Myeloid, Acute9
Multiple Myeloma9
Lymphoma8
Leukemia7
Leukemia, Lymphocytic, Chronic, B-Cell7
Blast Crisis6
Burkitt Lymphoma6
Congenital Abnormalities6
Hodgkin Disease6

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.